Kapitalo Investimentos Ltda Takes Position in UnitedHealth Group Incorporated $UNH

Kapitalo Investimentos Ltda purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 8,873 shares of the healthcare conglomerate’s stock, valued at approximately $3,064,000. UnitedHealth Group makes up 0.6% of Kapitalo Investimentos Ltda’s portfolio, making the stock its 29th biggest holding.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of UNH. North Capital Inc. boosted its stake in shares of UnitedHealth Group by 16.2% in the 3rd quarter. North Capital Inc. now owns 194 shares of the healthcare conglomerate’s stock valued at $67,000 after buying an additional 27 shares during the period. Sunflower Bank N.A. increased its position in shares of UnitedHealth Group by 1.5% in the 3rd quarter. Sunflower Bank N.A. now owns 1,916 shares of the healthcare conglomerate’s stock valued at $662,000 after purchasing an additional 28 shares during the last quarter. Axis Wealth Partners LLC lifted its position in shares of UnitedHealth Group by 1.7% during the 3rd quarter. Axis Wealth Partners LLC now owns 1,631 shares of the healthcare conglomerate’s stock worth $563,000 after purchasing an additional 28 shares during the last quarter. Abound Wealth Management raised its stake in UnitedHealth Group by 13.5% in the third quarter. Abound Wealth Management now owns 244 shares of the healthcare conglomerate’s stock valued at $84,000 after buying an additional 29 shares in the last quarter. Finally, Seamount Financial Group Inc. increased its holdings in shares of UnitedHealth Group by 4.7% in the 2nd quarter. Seamount Financial Group Inc. now owns 818 shares of the healthcare conglomerate’s stock valued at $255,000 after acquiring an additional 37 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on UNH shares. Wells Fargo & Company upped their price target on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Barclays increased their target price on shares of UnitedHealth Group from $386.00 to $391.00 and gave the company an “overweight” rating in a research report on Monday, January 5th. The Goldman Sachs Group assumed coverage on UnitedHealth Group in a report on Tuesday, October 14th. They set a “buy” rating and a $406.00 price objective on the stock. Deutsche Bank Aktiengesellschaft downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target on the stock. in a research note on Wednesday, October 29th. Finally, Piper Sandler restated an “overweight” rating on shares of UnitedHealth Group in a research report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $380.67.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q4 beat on EPS and margin commentary — UnitedHealth reported Q4 EPS of $2.11, slightly above consensus, and highlighted Optum Rx strength and margin initiatives that management says will support profitability. This gives some near-term earnings credibility despite revenue softness. MarketBeat Q4 coverage
• Positive Sentiment: Capital returns remain a cushion — analysts and commentators note UNH’s dividend and ongoing buybacks (share-count reduction planned) support the equity’s floor and long-term shareholder returns. That underpins buy-the-dip arguments. MarketBeat: Buying opportunity
• Neutral Sentiment: Allegations of timely politician sales are drawing attention — reports show some lawmakers sold UNH shares before the plunge; this is a political/PR risk but not a fundamental earnings driver. Watch regulatory/oversight headlines. Finbold: Politician sales
• Negative Sentiment: Weak 2026 guidance — management guided to roughly $439B in 2026 revenue (down from 2025), signaling a rare revenue contraction tied to “right-sizing” and lower reimbursement expectations; this is the principal reason investors stampeded out. Investopedia: Guidance and drivers
• Negative Sentiment: CMS/Medicare payment proposal (Trump administration) — a much-smaller-than-expected proposed increase to Medicare Advantage payments materially reduces forward reimbursement assumptions for insurers and magnified UNH’s guidance concerns. That policy news triggered the sector sell-off. Benzinga: Medicare rates reaction
• Negative Sentiment: Analysts cut price targets — multiple firms trimmed 12–30% off prior targets (Jefferies, Leerink, Oppenheimer, RBC, UBS), keeping buy/outperform ratings but lowering upside expectations — adds short-term selling pressure. TickerReport / Benzinga aggregation
• Negative Sentiment: Large one-day market cap hit and volatility — UNH lost tens of billions in market value and dragged the Dow lower; that amplifies risk aversion and forces some funds to trim exposure. InsiderMonkey: Market impact

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $294.08 on Thursday. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.82. The company has a market cap of $266.39 billion, a PE ratio of 15.35, a P/E/G ratio of 1.69 and a beta of 0.42. The stock has a fifty day moving average price of $331.78 and a 200 day moving average price of $323.60. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $2.09 by $0.02. The company had revenue of $113.22 billion during the quarter, compared to analysts’ expectations of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business’s revenue was up 12.3% on a year-over-year basis. During the same quarter last year, the business earned $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were paid a $2.21 dividend. The ex-dividend date was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.0%. UnitedHealth Group’s payout ratio is 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.